• Holly J Pederson, Zahraa Al-Hilli, and Allison W Kurian.
• Director, Medical Breast Services, Cleveland Clinic Breast Center, Cleveland Clinic, Cleveland, OH; Department of General Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH; Associate Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH; Former Member of the National Comprehensive Cancer Center Committees for Breast Cancer Risk Reduction and Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic pedersh@ccf.org.
• Cleve Clin J Med. 2022 Nov 1; 89 (11): 643-652.

AbstractBreast cancer remains the most common female malignancy in the United States. Reducing this cancer burden involves identification of high-risk individuals and personalized risk management. Because coronary artery disease remains the primary cause of death for women, any intervention to reduce breast cancer risk must be weighed against comorbidities and interventions affecting cardiovascular risk reduction. For select women at increased risk for breast cancer, preventive medication can greatly decrease risk and is vastly underutilized. Women's health clinicians are poised to evaluate risk, promote breast cancer risk reduction, and manage overall health.Copyright © 2022 The Cleveland Clinic Foundation. All Rights Reserved.

6 keywords...

hide…